Investing in Innovation and Growth

We are focused on developing novel therapeutics for rare dermatologic conditions while strategically managing our peptide assets to drive sustainable investor growth.

Helix BioMedix, Inc., is committed to building long term shareholder value through development of novel drugs for rare dermatological conditions with unmet needs and strategic management of our peptide library.

Transfer Agent

Broadridge Financial Solutions, Inc.

Website: www.shareholder.broadridge.com
E-mail: shareholder@broadridge.com
Telephone: 1-877-830-4936 or 720-378-5591

 

Mail: Broadridge Corporate Issuer Solutions, Inc.
P.O. Box 1342
Brentwood, NY 11717

 

INVESTOR RELATIONS CONTACT
E-mail: ir@helixbiomedix.com